Patient Safety Authority Logo

Skip navigation links
HOME
PATIENT SAFETY AUTHORITYExpand PATIENT SAFETY AUTHORITY
PA-PSRS and PASSKEYExpand PA-PSRS and PASSKEY
PATIENT SAFETY ADVISORIESExpand PATIENT SAFETY ADVISORIES
PATIENTS AND CONSUMERSExpand PATIENTS AND CONSUMERS
NEWS AND INFORMATIONExpand NEWS AND INFORMATION
EDUCATIONAL TOOLSExpand EDUCATIONAL TOOLS
AUTHORITY EVENTSExpand AUTHORITY EVENTS







ADDRESS:

Patient Safety Authority
333 Market Street
Lobby Level
Harrisburg, PA 17120


Phone: 717-346-0469
Fax: 717-346-1090


 
Advisory Banner
The Changing Faces of Unit-Dose
Tylenol Packets
PA PSRS Patient Saf Advis 2006 Mar;3(1):7. 
 

In the Fall of 2005, McNeil Consumer and Specialty Pharmaceuticals changed the packaging of its unit-dose TYLENOL (acetaminophen) 500 mg caplets for hospital use. The caplets, previously packaged in bright yellow packets, were switched to white packets to maximize accurate readability of the newly added bar code by scanning devices. Unfortunately, the new 500 mg packet looks virtually identical to the Tylenol 325 mg unit-dose packet (Figure 1). 

Figure 1. “New” white 500 mg unit-dose packet and 325 mg unit-dose packet look-alike.  Figure 1. “New” white 500 mg unit-dose packet and
  325 mg unit-dose packet (right) look-alike.

 

 

Pennsylvania healthcare facilities have reported multiple mixups involving these products to PA-PSRS. Practitioners have reported to ISMP and the manufacturer that the striking package similarities can lead to confusion and may result in excessive doses in facilities that do not use point-of-care bar coding.1 As a result of all the reports received, the manufacturer will be returning to the familiar yellow packet reportedly in March 2006 that includes a bar code (Figure 2) and will continue to explore ways to improve scanning reliability while maintaining visually differentiated packaging.2

Figure 2. Yellow Tylenol packet to return with barcode.

  Figure 2. Yellow Tylenol packet to return with barcode.

 

 

Notes

  1. ISMP Medication Safety Alert! Acute Care Edition. Look-alike Tylenol packets. 17 November 2005.
  2. ISMP Medication Safety Alert! Acute Care Edition. Your reports at work: Tylenol packaging returns to yellow. 26 January 2006.
 
 Browse by Topic
Navigation  



THE PENNSYLVANIA PATIENT SAFETY AUTHORITY AND ITS CONTRACTORS  
PSA LOGO The Pennsylvania Patient Safety Authority is an independent state agency created by Act 13 of 2002, the Medical Care Availability and Reduction of Error (“Mcare”) Act. Consistent with Act 13, ECRI Institute, as contractor for the Authority, is issuing this publication to advise medical facilities of immediate changes that can be instituted to reduce Serious Events and Incidents. For more information about the Pennsylvania Patient Safety Authority, see the Authority’s Web site at www.patientsafetyauthority.org .      
ECRI LOGO ECRI Institute, a nonprofit organization, dedicates itself to bringing the discipline of applied scientific research in healthcare to uncover the best approaches to improving patient care. As pioneers in this science for nearly 40 years, ECRI Institute marries experience and independence with the objectivity of evidence-based research. More than 5,000 healthcare organizations worldwide rely on ECRI Institute’s expertise in patient safety improvement, risk and quality management, and healthcare processes, devices, procedures and drug technology.      

ISMP Logo The Institute for Safe Medication Practices (ISMP) is an independent, nonprofit organization dedicated solely to medication error prevention and safe medication use. ISMP provides recommendations for the safe use of medications to the healthcare community including healthcare professionals, government agencies, accrediting organizations, and consumers. ISMP’s efforts are built on a nonpunitive approach and systems-based solutions.      
 
©2010 Pennsylvania Patient Safety Authority                                                Home      Who We Are      Contact Us     Subscribe to Advisories and Press Releases   Site Map     Privacy Statement